通用中文 | 注射用特利加压素 | 通用外文 | Terlipressin Acetate |
品牌中文 | 可立新 | 品牌外文 | GLYPRESSIN |
其他名称 | |||
公司 | FERRING(FERRING) | 产地 | 加拿大(Canada) |
含量 | 1mg | 包装 | 1支/盒 |
剂型给药 | 注射针剂 | 储存 | 室温 |
适用范围 | 胃肠道出血 |
通用中文 | 注射用特利加压素 |
通用外文 | Terlipressin Acetate |
品牌中文 | 可立新 |
品牌外文 | GLYPRESSIN |
其他名称 | |
公司 | FERRING(FERRING) |
产地 | 加拿大(Canada) |
含量 | 1mg |
包装 | 1支/盒 |
剂型给药 | 注射针剂 |
储存 | 室温 |
适用范围 | 胃肠道出血 |
· 【产品名称】注射用特利加压素
· 【商品名/商标】
可利新
· 【规格】1mg
· 【主要成份】本品主要化学成分:特利加压素。
· 【性状】白色冻干疏松块状物或粉末。
· 【适应症】
1.胃肠道出血,如食管静脉曲张出血、胃或十二指肠溃疡出血,以及其它胃肠道出血。2.泌尿生殖系统出血,如功能性或其它原因引起的子宫出血、生产或流产等引起的出血。3.术后出血的治疗,特别是腹腔和盆腔区域的出血。4.妇科手术的局部使用,如在子宫颈的手术。5.肝肾综合征,如(慢性肝炎、重型肝炎、肝硬化等)合并肝肾综合征,也用于肝移植患者术前术后肝肾综合征的治疗或预防等。6.顽固性(对儿茶酚胺抵抗性)休克,如败血症性休克等对扩容或和或儿茶酚胺等常规治疗无反应时。
· 【用法用量】1.治疗食管胃底静脉曲张出血:首剂2.0mg(用生理盐水稀释)静脉缓慢注射(超过1分钟),维持剂量为每4小时静脉缓慢注射1.0mg-2.0mg延续24~48小时,直至出血控制。建议出血停止后仍维持治疗1~2天,以防止再出血;其它胃肠道出血:对疑为上消化道出血的患者进行早期治疗时使用,可每4~6小时静脉缓慢注射1.0mg,连续用药,直至出血控制。本品也可作为急救药物使用。2.治疗泌尿生殖道出血:可每4~6小时静脉滴注0.2~1.0mg;用于治疗少女子宫出血时,建议给药剂量为5~20μg/千克体重。 3.用于儿童内脏出血:每4~8小时静脉给药一次,每次剂量为8~20μg/千克体重,连续用药,直至出血控制,治疗方式同成人。用硬化法治疗后的食管静脉曲张,建议采用20μg/千克体重一次性推注。 4.妇科手术后的局部应用:将0.4mg稀释于生理盐水至10ml,在子宫颈管内或子宫颈管旁注射给药,在给药后5~10分钟内观察疗效。若有必要,可重复给药。5.治疗肝肾综合征(1)(慢性肝炎、重型肝炎、肝硬化等合并)肝肾综合征:每8~12小时静脉缓慢注射1.0mg(也可将1.0mg溶于500ml糖水中静脉滴注),连续使用直至肾功改善。(2)对肝移植术前合并肝肾综合征的患者在等待接受肝移植术期间,每8~12小时静脉缓滴1.0~2.0mg(每次滴注时间约4小时),连续使用直至肾功恢复或直至接受肝移植术。也有术前每日使用10mg较大剂量的报道。(3)对肝移植术后没有合并肝肾综合征的患者,可术后每8小时予1.0mg静脉缓滴,2~3天,作为肝肾综合征的预防治疗;对肝移植术后合并肝肾综合征的患者,术后根据肾功受损程度予1.0~2.0mg静脉缓滴,每日3~4次,连续4~8天,直到肾功改善。(具体用法用量可根据临床情况进行调整)6.治疗顽固性休克,1mg静脉缓慢注射,每天1~2次;儿童用药,每4小时静脉缓慢注射20μg/千克体重。用药时间视血流动力学改善情况而定。使用中注意观察血压及心率。
· 【不良反应】使用本品治疗食管静脉曲张出血,可能会出现以下不良反应:1.由于具有收缩血管作用,患者会出现面部和体表苍白,以及血压轻微升高(高血压患者较为明显)。2.少数患者会出现心律失常,心动变缓和冠状动脉供血不足。3.偶见头痛或出现局部坏死。4.可能会加强蠕动运动而引致腹痛、恶心、腹泻。5.个别病例出现支气管肌肉痉挛而可能导致呼吸困难。6.可能会出现子宫肌肉痉挛,子宫肌肉和子宫内膜的血液循环障碍。7.虽然特利加压素抗利尿活性仅为天然加压素的3%,但曾报道有极个别病例出现低钠血和低钙血症,尤其是体液失衡患者。
· 【禁忌】1.败血性休克患者禁用;2.对本品过敏者禁用;3.本品对平滑肌有收缩作用,孕妇禁用。
· 【注意事项】1.本品的增压与抗利尿作用虽较赖氨酸加压素及精氨酸加压素低,但高血压、心脏功能紊乱或肾功能不全者仍应慎用。2.使用时应经常对患者血压、血清中钠、钾平衡进行监测。
· 【药物相互作用】1.非选择性β-阻滞剂对门静脉的降压作用会因联用本品而加强。2.应用含有静脉镇痛麻醉成分的药物(如异丙酚、舒芬太 尼)可降低心率和输出量,同时使用本品可能导致严重心动过缓。
· 【孕妇及哺乳期妇女用药】孕妇禁用。有关哺乳期用药的安全性未见有报道。
· 【老年患者用药】未进行该项试验且无可参考文献。
· 【药理毒理】特利加压素是人工合成的多肽,为垂体后叶分泌激素的类似物。注射给药后,它的三甘氨酰基会被体内酶切断而缓慢释放出活性物质如加压素,对平滑肌产生收缩作用,可持续10小时。加压素主要有两个方面的作用:一是明显的收缩血管作用,因而减少静脉血流流向肝门静脉系统,以致降低门静脉血压,具有止血作用;其二,能作用于肾脏上的某些受体,防止尿液中水分的过度流失,具有抗遗尿功能。 很多动物及人体试验证明,特利加压素本身并没有如加压素一样的激素活性。适当剂量的特利加压素可降低门静脉血压,但并不会像加压素一样,对静脉血压产生明显的改变。同时,特利加压素也不会增加纤维蛋白的溶解作用。毒理作用:本品的致突变试验结果呈阴性。
· 【生产厂家】德国:Ferring GmbH 分包装:辉凌制药
· 【生产地址】Wittland 11, D-24109 Kiel
Package leaflet: information for the user
Terlipressin Acetate 1mg solution for injection
(Terlipressin acetate)
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
■ Keep this leaflet. You may need to read it again.
■ If you have any further questions, ask your doctor, pharmacist or nurse.
■ This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
■ If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4.
What is in this leaflet:
1. What Terlipressin Acetate 1mg solution for injection is and what it is used for
2. What you need to know before you use Terlipressin Acetate 1mg solution for injection
3. How to use Terlipressin Acetate 1mg solution for injection
4. Possible side effects
5. How to store Terlipressin Acetate 1mg solution for injection
6. Contents of the pack and other information
1 What Terlipressin Acetate 1 mg solution for injection is and what it is used for
Terlipressin Acetate 1mg solution for injection is a synthetic pituitary hormone
Terlipressin Acetate 1mg solution for injection is used for the treatment of:
■ bleeding from dilated (widening) veins in the food pipe leading to your stomach (called bleeding oesophageal varices).
2 What you need to know before you start using Terlipressin Acetate 1mg solution for injection
Do not use Terlipressin Acetate 1mg solution for injection
■ if you are hypersensitive (allergic) to terlipressin or any of the other ingredients of Terlipressin Acetate 1mg solution for injection (see section 6).
Warnings and precautions
Talk to your doctor, pharmacist or nurse before you start using Terlipressin Acetate 1mg solution for injection
This medicine will be given to you if you have:
■ Severe or life threatening bleeding in your food pipe (oesophagus).
It is given under continous monitoring of your heart and blood circulation.
If you are able, please tell the doctor if you have any of the conditions shown below:
■ if you are suffering from a severe infection known as septic shock
■ if you suffer from bronchial asthma or other conditions that affect your breathing
■ if you suffer from uncontrolled high blood pressure, insufficient blood circulation in the heart vessels (e.g. angina), have previously had a heart attack (myocardial infarction), or you have hardening of the arteries (arteriosclerosis)
■ if you suffer from irregular heart beats (cardiac arrythmias)
■ if you have poor blood circulation to your brain (e.g. you have had a stroke) or to your limbs (peripheral vascular disease)
■ if you suffer from impaired kidney function (renal insufficiency)
■ if you suffer from disturbances in the level of salt (electrolytes) in your blood
■ if you are suffering from reduced amount of fluid in your circulation or have already lost a large amount of blood
■ if you are pregnant
■ if you are over the age of 70 years
Other medicines and Terlipressin Acetate 1mg solution for injection
Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.
Please inform your doctor immediately if you take any of the following medicines:
n drugs that have an effect on your heart rate (e.g. beta-blockers, sufentanil or propofol)
n drugs that can trigger irregular beating of the heart (arrhythmia) such as the following:
■ anti-arryhthmic drugs known as Class IA (quinidine, procainamide, disopyramide) and Class III (amiodarone, solatol, ibutilide, dofetilide)
■ an antibiotic called erythromycin
■ antihistamines (mainly used to treat allergies but also found in certain cough and cold remedies)
■ a type of medicine used to treat depression called tricyclic antidepressants
■ medicines that may alter the level of salt or electrolytes in your blood, particularly diuretics (used to treat high blood pressure and heart failure)
Terlipressin Acetate 1mg solution for injection with food and drink
There are no limitations.
Pregnancy and breast-feeding and fertility
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Ask your doctor or pharmacist for advice before taking any medicine.
Terlipressin Acetate 1mg solution for injection should only be used during pregnancy if it is vital to treat your condition.
It is not known if Terlipressin Acetate 1mg solution for injection is present in breast milk, therefore it is not known if there may be an effect on your baby. You should discuss the potential risk to your baby with your doctor.
Driving and using machines
No studies on the effects on the ability to drive and use machines have been performed.
Important information about some ingredients of Terlipressin Acetate 1mg solution for injection
Terlipressin Acetate 1mg solution for injection contains sodium
This medicinal product contains 30.6mg (1.33mmol) sodium per ampoule. To be taken into consideration by patients on a controlled sodium diet.
3 How to use Terlipressin Acetate 1mg solution for injection
This medicine is not to be used by yourself but will always be administered to you by your doctor. Please ask your doctor for further information regarding its use.
Adults
The dose will be determined by the doctor depending on patient’s weight.
Initially 1-2mg terlipressin acetate equivalent to 1-2 ampoules of Terlipressin Acetate 1mg solution for injection are administered. Your dose will depend on your body weight.
After the initial injection, your dose may be reduced to 1mg every 4 to 6 hours.
Treatment should be maintained for 24 consecutive hours until bleeding is under control or for a maximum period of 48 hours. After the initial injection, the following doses can be reduced to 1 milligram
(1 ampoule) of Terlipressin Acetate 1 mg solution for injection if necessary as, for example, by the occurrence of adverse reactions.
The maximum dose you can receive each day is approximately 120 microgrammes/kg body weight.
Elderly
If you are over 70 years of age speak with your doctor before you receive Terlipressin Acetate 1mg solution for injection
Use in children and adolescents
Terlipressin Acetate 1mg solution for injection is not recommended for use in children and adolescents due to insufficient experience.
Method and route of administration
After opening the ampoule, remove the solution with a syringe and inject it slowly intravenously.
Duration of treatment
The use of this medicine is limited to 2 – 3 days, depending on the course of your condition.
If you use more Terlipressin Acetate 1mg solution for injection than you should
You must not use more Terlipressin Acetate 1mg solution for injection than the recommended dose.
If you are given too much then you may have a rapid increase in your blood pressure, especially if you already suffer with high blood pressure. If this happens then you need another medicine called an alpha blocker (e.g. clonidine) to control your blood pressure.
You may also experience a low heart rate. This can be treated with a medicine called atropine.
If you forget to use Terlipressin Acetate 1mg solution for injection
You will be given Terlipressin Acetate 1mg solution for injection in hospital under the supervision of a doctor.
If you stop using Terlipressin Acetate 1mg solution for injection
If you have any further questions on the use of this medicine, ask your doctor or pharmacist or nurse.
4 Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Important side effects which need immediate attention:
In very rare cases, there may be severe side effects when you are given Terlipressin Acetate 1mg solution for injection.
If you are affected by any of the following side effects, please tell your doctor immediately if you are able to. Your doctor should not give you any more Terlipressin Acetate 1mg solution for injection to you.
■ severe shortness of breath due to an asthma attack
■ severe difficulty with or stopping breathing
■ severe pain in the chest (angina)
■ severe and persistent irregular heart beats
■ locally dead skin (necrosis)
■ convulsions (seizure)
■ kidney failure.
The following information is intended for medicinal or healthcare professionals only
Posology
Initially 1-2mg terlipressin acetate (equivalent to 1-2 ampoules of Terlipressin Acetate 1mg solution for injection) are administered.
Depending on the patient’s body weight the dose can be adjusted as follows:
■ weight less than 50kg: 1mg (1 ampoule of 8.5ml)
■ weight 50kg to 70kg: 1.5mg (1.5 ampoules of 8.5ml)
■ weight exceeding 70kg: 2mg (2 ampoules of 8.5ml).
After the initial injection, the dose can be reduced to 1mg every 4 to 6 hours.
The approximate value for the maximum daily dose of Terlipressin Acetate 1 mg solution for injection is 120 micrograms/kg body weight.
The therapy is to be limited to 2 – 3 days in adaptation to the course of the disease.
Terlipressin Acetate 1mg solution for injection is injected intravenously and should be given over a period of one minute.
Terlipressin Acetate 1mg solution for injection should only be used with caution in patients over 70 years, and patients with chronic renal failure.
Terlipressin Acetate 1mg solution for injection is not recommended in children and adolescents due to insufficient experience on safety and efficacy.
A dose adjustment is not required in patients with liver failure.
Preparation of the injection:
Terlipressin Acetate 1mg solution for injection is dissolved with the accompanying solvent and is applied intravenously.
The solution should be inspected visually for particles and discolouration prior to administration.
Do not use Terlipressin Acetate 1mg solution for injection if you notice
■ That the solution discolours. Store in a refrigerator at 2-8˚C.
Keep the vial in the outer carton to protect from light.
After reconstitution the solution should be used immediately.
For single use only. Discard any unused solution.
Frequency of possible side effects:
Common (affects less than 1 in 10 people):
Heart and circulation
■ very slow heart rate
■ signs of insufficient blood circulation in the heart vessels in the ECG
■ high or low blood pressure
■ insufficient blood circulation in arms, legs and skin
■ paleness of face
■ pale skin
General
■ headache
Stomach and gut
■ temporary abdominal cramps
■ temporary diarrhoea
■ abdominal cramps (in women)
Uncommon (affects less than 1 in 100 people):
Mind and nervous system
■ triggering of a fit
Heart and circulation
■ chest pain
■ rapid increase in blood pressure
■ heart attack
■ irregular heart rate
■ too fast heart rate (palpitations)
■ bluish colouration of the skin or lips
■ hot flushes
■ heart failure (Torsade de Pointes)
Lungs and breathing
■ excess fluid on the lungs
■ shortness of breath due to spasm in the bronchial muscles
■ severe difficulty with or stopping breathing
Stomach and gut
■ temporary nausea
■ temporary vomiting
General
■ inflammation of the lymph vessels
■ reduced blood supply to the intestinal system
■ uterine cramps
■ decreased blood flow to the uterus
■ dead skin (necrosis) not related to the injection site
Results of blood tests
■ too little sodium in the blood (hyponatraemia) if not monitored
Rare (affects less than 1 in 1000 people):
Lungs and breathing
■ shortness of breath
Very rare (affects less than 1 in 10,000 people):
Heart and circulation
■ stroke
■ severe angina
Results of blood tests
■ too much sugar in the blood (hyperglycaemia)
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the United Kingdom Yellow Card Scheme.
Website: www.mhra.gov.uk/yellowcard
By reporting side effects you can help provide more information on the safety of this medicine.
What Terlipressin Acetate 1mg solution for injection looks like and contents of the pack
This medicine is presented as a solution for injection. It is supplied in clear Type I glass ampoules containing solution for injection.
Each ampoule contains 8.5ml of solvent.
Terlipressin Acetate 1mg solution for injection is a clear, colourless solution for injection.
This medicine is available in pack sizes of:
One carton with 5 ampoules with 8.5ml of solution.
Marketing Authorisation Holder and Manufacturer
Marketing Authorisation Holder
Inresa Arzneimittel GmbH
Obere Hardtstraße 18
79114 Freiburg
Germany
Manufacturer
GENFARMA LABORATORIO, S.L.
Avda de la Constitución 199, P.I. Monte Boyal 45950 Casarrubios del Monte (Toledo) Spain
and
Inresa Arzneimittel GmbH
Obere Hardtstraße 18
79114 Freiburg
Germany
This medicinal product is authorised in the Member States of the EEA under the following names:
DE: TERLIPRESSIN 1mg SOLUTION FOR INJECTION
UK: TERLIPRESSIN ACETATE 1mg SOLUTION FOR INJECTION
This leaflet was last revised in October 2016
5 How to store Terlipressin Acetate 1mg solution for injection
Keep this medicine out of the sight and reach of children.
Store in a refrigerator at 2-8˚C. Keep in the original
package in order to protect from light.
The reconstituted Terlipressin Acetate 1mg solution for
injection -solution has to be used immediately.
Do not use this medicine after the expiry date which is
stated on the pack after EXP. The expiry date refers to
the last day of that month.
Do not use Terlipressin Acetate 1mg solution for injection
if you notice
■ that the solution discolours.
Do not throw away any medicines via wastewater or
household waste. Ask your pharmacist how to throw
away medicines you no longer use. These measures will
help protect the environment.
6 Contents of the pack and other information
What Terlipressin Acetate 1mg solution for
injection contains
■ The active substance is terlipressin acetate.
Each ampoule contains: 1mg of terlipressin acetate in
8.5ml solution for injection, corresponding to 0.85mg
terlipressin.
1ml of solution for injection contains 0.12mg/ml of
terlipressin acetate, equivalent to 0.1mg terlipressin.
■ The other ingredients are:
sodium chloride, glacial acetic acid, sodium acetate and
water for injection.